UDG Healthcare Public Limited Co. Directorate Change (8169K)

TIDMUDG

RNS Number : 8169K

UDG Healthcare Public Limited Co.

26 September 2016

UDG Healthcare PLC

26 September 2016

Directorate Change

UDG Healthcare plc ("the Group"), a leading international provider of healthcare services, announces that Chris Corbin, CEO of Ashfield Commercial & Medical Services, has advised of his intention to retire from the Group in April 2019. In preparation for his retirement, Chris will transition to the role of Chairman of Ashfield once his successor has been appointed. This will facilitate a phased transition of Chris's responsibilities over the next two and half years. In addition, Chris will remain as a member of the Board of Directors of UDG Healthcare until his retirement.

Brendan McAtamney, CEO of UDG Healthcare, said: "I would like to thank Chris for his substantial contribution to the success of both the Group and Ashfield since joining us in 2000. Under his leadership, Ashfield has developed into a leading international healthcare services organisation and a key division of the Group. We will work closely with Chris over the next two and a half years to ensure a professional transition process and thereafter wish him the very best in retirement".

 
 For further information, please contact: 
 Investors and Analysts: 
  Alan Ralph                     Keith Byrne 
  CFO                            Head of Investor Relations, 
  UDG Healthcare plc             Strategy & Corporate Communications 
  Tel: [phone]           UDG Healthcare plc 
                                 Tel: + 353-1-468-9000 
 

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering clinical, commercial, communication and packaging services to the healthcare industry, employing over 7,000 employees at operations across 20 countries including the US, UK, Ireland and Germany.

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Aquilant Specialist Healthcare Services.

Ashfield Commercial & Medical Services is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial and clinical services, and healthcare communications. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance (drug safety), regulatory and event management services to over 300 healthcare companies in 18 countries.

Sharp Packaging Services is a global leader in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Aquilant Specialist Healthcare Services is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOABGGDCXGDBGLL

(END) Dow Jones Newswires

September 26, 2016 06:10 ET (10:10 GMT)